insitro

📍 South San Francisco, United States🗓 Founded 2018👥 314 employees💰 Last funded Feb 2021
Biotechnology Research🌐 insitro.com
Website LinkedIn
insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients. At insitro, we are rethinking the entire drug discovery process, from the perspective of machine learning, human genetics, and high-throughput, quantitative biology. Over the past five decades, we have seen the development of new medicines becoming increasingly more difficult and expensive, leaving many patients with significant unmet need. We’re embarking on a new approach to drug development – one that leverages machine learning and unique in vitro strategies for modeling disease state and designing new therapeutic interventions. We aim to eliminate key bottlenecks in traditional drug discovery, so we can help more people sooner and at a much lower cost to the patient and the healthcare industry. We believe that by harnessing the power of technology to interrogate and measure human biology, we can have a major impact on many diseases. We invest heavily in cutting edge bioengineering technologies to enable the construction of large-scale, high-quality data sets that are designed specifically to drive machine learning methods. Our first application is to use human genetics, functional genomics, and machine learning to build a new generation of in vitro human cell-derived disease models whose response to perturbation is designed to be predictive of human clinical outcomes. This cannot be done without great people. We are bringing together an outstanding team of people whose expertise spans multiple disciplines - life sciences, machine learning, human genetics, engineering, and drug discovery - and building a unique culture where people from diverse backgrounds work as a single team towards a common goal. We offer opportunities to collaborative people with expertise in life science and computational science. Join us to help bring better health to more people, faster and cheaper.
11
Total investors
10
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

11 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
9
United Arab Emirates
1
Investor activity2018–2021 · investors recorded per year
20184201912020520211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in insitro?
insitro has 11 investors on record on gritt.io, including 10 early-stage backers, 1 mid-stage.
When did insitro last raise funding?
The most recent investment in insitro recorded on gritt.io was in February 2021.
When was insitro founded?
insitro was founded in 2018.
What industry is insitro in?
insitro operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is insitro based?
insitro is headquartered in South San Francisco, United States.